ArticleInternational journal of general medicine2025
Assessing the Knowledge and Prescription Practice of Gastroenterologists and Pharmacists Toward Probiotics in Saudi Arabia: An Electronic Survey-Based Study.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Use of Probiotics with Antibiotics: Knowledge, Attitudes, and Practices in Community Pharmacy.Healthcare (Basel, Switzerland) · 2026Article
- Knowledge, Attitudes, and Practices Regarding Probiotic Use in Enteral Feeding Among Intensive Care Unit Healthcare Professionals.Healthcare (Basel, Switzerland) · 2026Article
- Pharmacists Knowledge, Attitudes, and Practices Regarding Probiotics and Prebiotics: A Cross-Sectional Study from Palestine.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Probiotics are live microorganisms that provide many benefits to the human body when supplemented with a diet. In Saudi Arabia, there are limited studies on the use of probiotic supplements for some gastrointestinal inflammatory and infectious conditions. Many health professionals who provide health care for patients with gastrointestinal conditions may recommend probiotics at different degrees based on their knowledge and experience. This study aimed to explore the knowledge and practice of gastroenterologists and pharmacists in Saudi Arabia regarding probiotics. Methods: We measured the practice of recommending, prescribing, and using probiotics by analyzing the responses of the healthcare specialists (gastroenterologists and pharmacists) using an anonymous online survey. The survey was constructed to explore the knowledge, use, and manner of prescribing probiotics by healthcare practitioners in the Saudi community to discuss health benefits with patients with gastrointestinal conditions. Results: Most gastroenterologists (61.5%) partially disagreed that probiotics could benefit the treatment of digestive symptoms. However, a third of the pharmacists agreed that probiotic products could relieve digestive symptoms. The attitude toward and practice of prescribing probiotics depend on many factors, including professionals' beliefs in the benefits of probiotics, insufficient evidence from previous studies and clinical trials about the beneficial use of probiotics, cost, and manufacturing brands. Conclusion: Gastroenterologists' and pharmacists' knowledge of probiotics was up to date as evident by their ability to identify specific digestive disorders for which probiotics may be beneficial, as well as their rejection of the notion that probiotics are universally effective in all gastrointestinal disorders, which is a commonly held belief in the community. The cost of probiotics as supplements to dairy products or as brands alone may also affect the prescription of probiotics by health professionals, as shown in the current study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.